GGrantIndex
← Leaderboards

Sofiya Milman

Albert Einstein College Of Medicine

Google Scholar ↗PubMed ↗ORCID ↗
$8,537,228
Attributed
$11,497,551
Total exposure
9
Grants
7
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.8M · FY2015–25
$5M$3.8M$2.5M$1.3M$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$11,497,551 · 9

By mechanism

R01$8,578,724 · 4
R56$846,303 · 1
K23$790,881 · 1
P30$783,979 · 2
R41$497,664 · 1

Top collaborators

Most similar at Albert Einstein College Of Medicine

Same institution · by research overlap

Others in their field

Top investigators on “Alzheimer&Apos”

Research focus

Alzheimer&AposAgingAge RelatedPathway InteractionsLongevityGeneticCohortCentenarianBiologicalOffspringRisk FactorsDementiaFollow-UpIncidenceUnited StatesFamilyInheritedGenetic VariantSignal TransductionAttenuatedLeadPhenotypeInsulin-Like Growth Factor IBiology Of Aging

Grant awards (25)

CH in Aging and Exceptional Longevity$1,064,072
R01 · FY2025 · AG
Multi-omics approach to frailty resilience$689,031
R01 · FY2025 · AG · contact PI
Development of a Growth Hormone Receptor antagonist for the delay or prevention of ADRD$222,594
R41 · FY2025 · AG
CH in Aging and Exceptional Longevity$1,085,789
R01 · FY2024 · AG
Trajectories and modifiable risk factors of brain, gait, and cognitive decline in aging and pre-dementia$769,368
R01 · FY2024 · AG · contact PI
Multi-omics approach to frailty resilience$719,587
R01 · FY2024 · AG · contact PI
Development of a Growth Hormone Receptor antagonist for the delay or prevention of ADRD$275,070
R41 · FY2024 · AG
Somatotropic Signaling and Resilience to Aging and Alzheimer's Disease$829,389
R01 · FY2023 · AG · contact PI
Einstein's Nathan Shock Center of Excellence in Basic Biology of Aging$195,065
P30 · FY2023 · AG · contact PI
Somatotropic Signaling and Resilience to Aging and Alzheimer's Disease$829,389
R01 · FY2022 · AG · contact PI
Einstein's Nathan Shock Center of Excellence in Basic Biology of Aging$196,306
P30 · FY2022 · AG · contact PI
Multi-omics approach to frailty resilience$846,303
R56 · FY2021 · AG · contact PI
Somatotropic Signaling and Resilience to Aging and Alzheimer's Disease$782,490
R01 · FY2021 · AG · contact PI
Cognitive and Emotional Resilience to the COVID-19 pandemic among older adults at risk for Alzheimer's disease$241,129
R01 · FY2021 · AG · contact PI
Einstein's Nathan Shock Center of Excellence in Basic Biology of Aging$196,306
P30 · FY2021 · AG · contact PI
Somatotropic Signaling and Resilience to Aging and Alzheimer's Disease$782,490
R01 · FY2020 · AG · contact PI
Einstein's Nathan Shock Center of Excellence in Basic Biology of Aging$196,302
P30 · FY2020 · AG · contact PI
Somatotropic Signaling and Resilience to Aging and Alzheimer's Disease$785,990
R01 · FY2019 · AG · contact PI
Effect of longevity genomes on the GH/IGF-1 phenotype and disease-free survival$88,671
K23 · FY2018 · AG · contact PI
Effect of longevity genomes on the GH/IGF-1 phenotype and disease-free survival$84,129
K23 · FY2018 · AG · contact PI
Effect of longevity genomes on the GH/IGF-1 phenotype and disease-free survival$172,800
K23 · FY2017 · AG · contact PI
Effect of longevity genomes on the GH/IGF-1 phenotype and disease-free survival$99,681
K23 · FY2017 · AG · contact PI
Effect of longevity genomes on the GH/IGF-1 phenotype and disease-free survival$172,800
K23 · FY2016 · AG · contact PI
Effect of longevity genomes on the GH/IGF-1 phenotype and disease-free survival$122,040
K23 · FY2015 · AG · contact PI
Effect of longevity genomes on the GH/IGF-1 phenotype and disease-free survival$50,760
K23 · FY2015 · AG · contact PI